Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca ...

Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...

Lily Phillips has never been one to shy away from giving out too much information, and in a recent vlog video with an ...

JACKSONVILLE — Lilly Ledbetter grew up poor in the Possum Trot community north of Jacksonville. Despite her oft-drunken father and her downtrodden mother, she graduated from high school, married and ...

The weather wasn’t fantastic at Northern Bedford High School for its annual track and field invitational on Friday, but ...

Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, ...

Eli Lilly is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the first healthcare company to do so.Trading at $852 per share, LLY ...

Eli Lilly’s shares shot up 11% pre-market on Thursday after orforglipron became the first small-molecule GLP-1 drug to ace a ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best American dividend stocks. Dividend-paying stocks have long benefited investors by ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes. By Rebecca Robbins and Gina Kolata Encouraging ...